Abnormalities in Signaling Pathways in Diabetic Nephropathy

Overview

Journal Expert Rev Endocrinol Metab

Specialty Endocrinology

Date 2010 Mar 13

PMID 20224802

Citations 54

Authors

Frank C Brosius

Charbel C Khoury

Carolyn L Buller

Sheldon Chen

Affiliations

Soon will be listed here.

Abstract

Diabetic nephropathy (DN) is characterized by a plethora of signaling abnormalities that together ultimately result in the clinical and pathologic hallmarks of DN, namely progressive albuminuria followed by a gradual decline in glomerular filtration rate leading to kidney failure, and accompanied by podocyte loss, progressive glomerular sclerosis and, ultimately, progressive tubulointerstitial fibrosis. Over the past few years, the general understanding of the abnormalities in signaling pathways that lead to DN has expanded considerably. In this review, some of the important pathways that appear to be involved in driving this process are discussed, with special emphasis on newer findings and insights. Newer concepts regarding signaling changes in bradykinin, mTOR, JAK/STAT, MCP-1, VEGF, endothelial nitric oxide synthase, activated protein C and other pathways are discussed.

Citing Articles

Circular RNAs and the regulation of gene expression in diabetic nephropathy (Review).

Benitez M, Navarro Y, Azuara-Liceaga E, Cruz A, Flores J, Lopez-Canovas L Int J Mol Med. 2024; 53(5).

PMID: 38516776 PMC: 10998718. DOI: 10.3892/ijmm.2024.5368.

The Role of the Epidermal Growth Factor Receptor in Diabetic Kidney Disease.

Harris R Cells. 2022; 11(21).

PMID: 36359813 PMC: 9656309. DOI: 10.3390/cells11213416.

Comparative co-expression analysis of RNA-Seq transcriptome revealing key genes, miRNA and transcription factor in distinct metabolic pathways in diabetic nerve, eye, and kidney disease.

Asmy V, Natarajan J Genomics Inform. 2022; 20(3):e26.

PMID: 36239103 PMC: 9576479. DOI: 10.5808/gi.22029.

Ameliorates Streptozotocin-Induced Diabetic Nephropathy through Antioxidant and Anti-Inflammatory Pathways.

Dey P, Kundu A, Lee H, Kar B, Vishal V, Dash S Molecules. 2022; 27(15).

PMID: 35956936 PMC: 9370403. DOI: 10.3390/molecules27154985.

Identification of CCL19 as a Novel Immune-Related Biomarker in Diabetic Nephropathy.

Chen H, Zhang Z, Zhou L, Cai T, Liu B, Wang L Front Genet. 2022; 13:830437.

PMID: 35222545 PMC: 8864156. DOI: 10.3389/fgene.2022.830437.

References

Hoshi S, Nomoto K, Kuromitsu J, Tomari S, Nagata M . High glucose induced VEGF expression via PKC and ERK in glomerular podocytes. Biochem Biophys Res Commun. 2002; 290(1):177-84. DOI: 10.1006/bbrc.2001.6138. View

Satchell S, Anderson K, Mathieson P . Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties. J Am Soc Nephrol. 2004; 15(3):566-74. DOI: 10.1097/01.asn.0000115397.22519.03. View

Wang Y, Chen J, Chen L, Tay Y, Rangan G, Harris D . Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol. 1997; 8(10):1537-45. DOI: 10.1681/ASN.V8101537. View

Dreieicher E, Beck K, Lazaroski S, Boosen M, Tsalastra-Greul W, Beck M . Nitric oxide inhibits glomerular TGF-beta signaling via SMOC-1. J Am Soc Nephrol. 2009; 20(9):1963-74. PMC: 2736775. DOI: 10.1681/ASN.2008060653. View

Hohenstein B, Hausknecht B, Boehmer K, Riess R, Brekken R, Hugo C . Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int. 2006; 69(9):1654-61. DOI: 10.1038/sj.ki.5000294. View

Jin D, Fish A, Wayner E, Mauer M, Setty S, Tsilibary E . Distribution of integrin subunits in human diabetic kidneys. J Am Soc Nephrol. 1996; 7(12):2636-45. DOI: 10.1681/ASN.V7122636. View

Navarro J, Milena F, Mora C, Leon C, Garcia J . Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration. Am J Nephrol. 2006; 26(6):562-70. DOI: 10.1159/000098004. View

Mohan S, Reddick R, Musi N, Horn D, Yan B, Prihoda T . Diabetic eNOS knockout mice develop distinct macro- and microvascular complications. Lab Invest. 2008; 88(5):515-28. DOI: 10.1038/labinvest.2008.23. View

Prabhakar S . Role of nitric oxide in diabetic nephropathy. Semin Nephrol. 2004; 24(4):333-44. DOI: 10.1016/j.semnephrol.2004.04.005. View

10.

Wu D, Bitzer M, Ju W, Mundel P, Bottinger E . TGF-beta concentration specifies differential signaling profiles of growth arrest/differentiation and apoptosis in podocytes. J Am Soc Nephrol. 2005; 16(11):3211-21. DOI: 10.1681/ASN.2004121055. View

11.

Inoki K . Role of TSC-mTOR pathway in diabetic nephropathy. Diabetes Res Clin Pract. 2008; 82 Suppl 1:S59-62. DOI: 10.1016/j.diabres.2008.09.028. View

12.

Schiffer M, Bitzer M, Roberts I, Kopp J, Ten Dijke P, Mundel P . Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest. 2001; 108(6):807-16. PMC: 200928. DOI: 10.1172/JCI12367. View

13.

Najafian B, Kim Y, Crosson J, Mauer M . Atubular glomeruli and glomerulotubular junction abnormalities in diabetic nephropathy. J Am Soc Nephrol. 2003; 14(4):908-17. DOI: 10.1097/01.asn.0000057854.32413.81. View

14.

Schmid H, Boucherot A, Yasuda Y, Henger A, Brunner B, Eichinger F . Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes. 2006; 55(11):2993-3003. DOI: 10.2337/db06-0477. View

15.

Logar C, Brinkkoetter P, Krofft R, Pippin J, Shankland S . Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo. Kidney Int. 2007; 72(4):489-98. DOI: 10.1038/sj.ki.5002362. View

16.

Burt D, Salvidio G, Tarabra E, Barutta F, Pinach S, Dentelli P . The monocyte chemoattractant protein-1/cognate CC chemokine receptor 2 system affects cell motility in cultured human podocytes. Am J Pathol. 2007; 171(6):1789-99. PMC: 2111103. DOI: 10.2353/ajpath.2007.070398. View

17.

Hirano T, Kashiwazaki K, Moritomo Y, Nagano S, Adachi M . Albuminuria is directly associated with increased plasma PAI-1 and factor VII levels in NIDDM patients. Diabetes Res Clin Pract. 1997; 36(1):11-8. DOI: 10.1016/s0168-8227(97)01384-3. View

18.

Nakagawa T . Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease. Am J Physiol Renal Physiol. 2007; 292(6):F1665-72. DOI: 10.1152/ajprenal.00495.2006. View

19.

Babazono T, Dlugosz J, Whiteside C . Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells. Diabetes. 1998; 47(4):668-76. DOI: 10.2337/diabetes.47.4.668. View

20.

FISHER E, McLennan S, Yue D, Turtle J . High glucose reduces generation of plasmin activity by mesangial cells. Microvasc Res. 1997; 53(2):173-8. DOI: 10.1006/mvre.1996.2006. View